| Net sales | 151.93M |
| Cost of products sold | 102.2M |
| Gross profit | 49.73M |
| Selling expenses | 19.03M |
| General and administrative expenses | 16.31M |
| Restructuring charges | |
| Amortization of intangibles | 1.77M |
| Total operating expenses | 37.11M |
| Income (loss) from operations | 12.62M |
| Interest and debt expense | 2.53M |
| Investment income | -88K |
| Foreign currency exchange (loss) gain | -220K |
| Other income, net | -48K |
| (Loss) income from continuing operations before income tax expense (benefit) | 10.45M |
| Income Tax Expense Benefit | 3.63M |
| Income from discontinued operations | |
| ProfitLoss | 6.82M |
| New Accounting Pronouncement Or Change In Accounting Principle Name | |
| (Accumulated Deficit) retained earnings - beginning of period | 180.57M |
| Accumulated deficit (retained earnings) - end of period | 186.58M |
| Weighted Average Number Of Shares Outstanding Basic | 20.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 20.37M |
| Earnings Per Share Basic | 0.34 |
| Earnings Per Share Diluted | 0.33 |